Eric Crowell is an Ophthalmology physician affiliated with Rutgers. OpenAlex indexes 66 publications with 399 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1601 Trinity St
Austin, TX 787121765
Telephone
833-882-2737Provider last certified this registry record 26 Aug 2025.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bausch & Lomb Americas Inc.Program year20257 payments
- Sight Sciences, Inc.Program year20255 payments
- ABBVIE INC.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
55.6%Corticosteroid14.7%Prednisolone Acetate100%Part D≥22 patientsCarbonic Anhydrase Inhibitor11.3%Dorzolamide-Timolol100%Part D≥12 patients+ 4 more classes in this area
Cancer & immunology
34.8%Calcineurin inhibitor28%Restasis65%Cyclosporine35%Part D≥22 patientsFolate Analog Metabolic Inhibitor6.8%Methotrexate100%Part D<11 patientsAnti-infectives
5.1%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor5.1%Valacyclovir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Expanded Spectrum of Chrysanthemum and Miliary Multifocal Choroiditis With Panuveitis: Novel Imaging and Pathophysiological Insights
American Journal of Ophthalmology
2026 - Biologics Use Disparities in Non-Infectious Uveitis: A National Study of Social Determinants of Health
Ocular Immunology and Inflammation
2026 - Elimination of “lag” and “burst” phases in drug release profiles of melt-extruded, PLGA-based intravitreal implants
International Journal of Pharmaceutics
2025 - The Effect of Metagenomic Sequencing on Patient Clinical Outcomes for Intraocular Infections: A Multicenter Randomized Controlled Trial
American Journal of Ophthalmology
2025 - Barriers to Adherence with Clinic Visits in Patients with Uveitis
Ocular Immunology and Inflammation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Sherine Gabriel, MD
Rutgers
Julius Gardin, MD
Rutgers
Abraham Aviv, MD
Rutgers
Partho Sengupta, MD, DM
Rutgers
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”